Interview with Jeff Davis, CEO of Access Pharmaceuticals (OTCBB: ACCP) by Tom Allinder

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
385 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Jul 27, 2009

A short interview with Jeff Davis, CEO of Access Pharmaceuticals (OTCBB: ACCP) by Tom Allinder of ProActiveNewsRoom.com. A discussion of recent results regarding one of the Company's flagship products, MuGard.

Category:

Science & Technology

Tags:

License:

Standard YouTube License

  • likes, 0 dislikes

Link to this comment:

Share to:
see all

All Comments (1)

Sign In or Sign Up now to post a comment!
  • Instead of creating products that offset the side effects of chemo which has proven not to work-this is just another pharma product-to prolong diseases.

    Chemo is primitive medicine-and should be abandoned completely -it is ancient medicine that kills healthy cells and does nothing to prevent cancer or cure it.

    This is just another money maker for the drug company-bad science in the wrong direction.

Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more